RLAY · NASDAQ · Biotechnology

Relay Therapeutics

Designs small-molecule medicines around protein motion for cancer and genetic disease.

$19.10
After-hours close+0.34 (+1.82%)
At close$18.76(−3.40%)
DateEstimateReportedSurprise
Nov 2026−$0.40
Aug 2026−$0.39−$0.41−4.8%
May 2026−$0.36−$0.41−12.9%
Feb 2026−$0.38−$0.32+15.8%
Nov 2025−$0.39−$0.43−10.3%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
Jul 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 5, 2026−$0.40$1.6M
Aug 6, 2026−$0.39−$0.41−4.8%$960.0K$350.0K−63.5%
May 5, 2026−$0.36−$0.41−12.9%$5.6M$3.0M−46.2%
Feb 26, 2026−$0.38−$0.32+15.8%$5.0M$7.0M+41.0%
Nov 6, 2025−$0.39−$0.43−10.3%$5.0M

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
Aug 7, 2025
May 5, 2025
Feb 26, 2025
Nov 6, 2024
Aug 6, 2024
May 2, 2024
Feb 22, 2024
Nov 2, 2023
Aug 8, 2023
May 4, 2023
Feb 23, 2023
Nov 3, 2022
Aug 4, 2022
May 5, 2022
Feb 24, 2022
Nov 10, 2021
Aug 12, 2021
May 13, 2021
Mar 25, 2021
Nov 12, 2020
Aug 27, 2020
Jul 9, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019